Comment on

• Time-dependent benefit of preventive cardiac resynchronization therapy after myocardial infarction.

  Barsheshet A, Moss AJ, Eldar M, Huang DT, Hall WJ, Klein HU, McNitt S, Steinberg JS, Wilber DJ, Zareba W, Goldenberg I. Barsheshet A, et al. Eur Heart J. 2011 Jul;32(13):1614-21. doi: 10.1093/eurheartj/ehq392. Epub 2010 Nov 12. Eur Heart J. 2011. PMID: 21075773 Clinical Trial.
• Response to preventive cardiac resynchronization therapy in patients with ischaemic and nonischaemic cardiomyopathy in MADIT-CRT.

  Barsheshet A, Goldenberg I, Moss AJ, Eldar M, Huang DT, McNitt S, Klein HU, Hall WJ, Brown MW, Goldberger JJ, Goldstein RE, Schuger C, Zareba W, Daubert JP. Barsheshet A, et al. Eur Heart J. 2011 Jul;32(13):1622-30. doi: 10.1093/eurheartj/ehq407. Epub 2010 Nov 12. Eur Heart J. 2011. PMID: 21075774 Clinical Trial.
• Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction).

  Linde C, Mealing S, Hawkins N, Eaton J, Brown B, Daubert JC; REVERSE study group. Linde C, et al. Eur Heart J. 2011 Jul;32(13):1631-9. doi: 10.1093/eurheartj/ehq408. Epub 2010 Nov 25. Eur Heart J. 2011. PMID: 21112898 Clinical Trial.